Trial · NCT06250257
Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive Age
NCT06250257, Phase 3, Recruiting, Jimma University
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive Age. Trials, record NCT06250257. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06250257
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Bromocriptine in Dilated Cardiomyopathy Among Women of Reproductive Age
- NCT number
- NCT06250257
- Status
- Recruiting
- Phases
- Phase 3
- Enrollment
- 112 participants, estimated
- Lead sponsor
- Jimma University
- Conditions
- Dilated Cardiomyopathy
- Interventions
- Bromocriptine mesylate plus standard GDMT
- First posted
- 2024-02-09
- Last updated
- 2024-11-19
Source ClinicalTrials.gov
Registered outcomes6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Left ventricular function improvement | at 3, 6 and 9 months | Left ventricular function change measured in terms of ejection fraction and fractional shortening. |
| Primary | Improvement of cardiac biomarkers (N-terminal Pro BNP) | Measured at 3, 6 and 9 months | Change in cardiac biomarkers measured as N-terminal Pro BNP. |
| Primary | Clinical improvement assessment tests | At recruitment, at 3,6, 9 and 12 months | Exercise capacity improvement test with 6-minute walk test and stair climbing tests |
| Secondary | Change in hospitalization pattern | At 9 months and 1 year | Change in hospitalization as compared with measurements before and after intervention |
| Secondary | Functional class of heart failure Improvement | At 9 months and one year | Change in NYHAF class as measured clinically and compared to the baseline status. |
| Secondary | Improved quality of life | At 9 months and one year | Change in quality of life as measured by Kansas City Cardiomyopathy Questionnaire (KCCQ-12) updated questionnaire, all KCCQ scores will be scaled from 0 to 100 and frequently summarized in 25-point ranges, where scores represent health status as follows: 0 to 24: very poor to poor; 25 to 49: poor to fair; 50 to 74: fair to good; and 75 to 100: good to excellent. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers24
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06250257
GET https://conductscience.org/api/trials/v1/NCT06250257/papers?page=2